Latest News about Exclusives
Recent news which mentions Exclusives
Private Equity Goes Cold On IPOs: We Offer A Better Alternative, Says Canaccord Genuity Manager
March 01, 2024
From Benzinga
From Benzinga
From Benzinga
Former Congressman Battles Legislative Barriers For Crucial Cannabis Banking Legislation
March 01, 2024
From Benzinga
Exclusive: Is Dogecoin Going Legit? Landmark Sale Could Change The Way We Buy Homes
February 29, 2024
Tickers
NEWS
From Benzinga
EXCLUSIVE: How Cannabis Companies Can Pay 'Zero Taxes' — The Industry's Best Kept Secret
February 29, 2024
From Benzinga
EXCLUSIVE: Magnificent 7 Takes Center Stage In Roundhill's Expanded ETF Lineup With Inverse And Leveraged Options
February 29, 2024
From Benzinga
Podcast - Post-Frenzy Psychedelics Investing And Reclaiming The Right To Pursue Happiness With Zappy Zapolin: '2024 Is When It Goes Mainstream'
February 29, 2024
From Benzinga
EXCLUSIVE: Enveric Biosciences Announces Non-Binding Deals To License Out Three Types of Drug Compounds
February 29, 2024
From Benzinga
Curaleaf Price Target Spikes, Fueled By German Cannabis Legalization Changes — ROTH MKM Explains
February 28, 2024
From Benzinga
This Ain't 1999: 'Nvidia Is Cheaper Than It Was 26 Months Ago' — Market Expert Says Magnificent 7 Stocks Are Not In A Bubble
February 28, 2024
Tickers
NVDA
From Benzinga
A New Financing Option For Cannabis Companies Launches: Understanding The Importance Of Being At The Right Place
February 28, 2024
From Benzinga
EXCLUSIVE: ETFs Vs. Mutual Funds — Why Main Management's Darol Ryan Expects Further Conversions In 2024
February 28, 2024
From Benzinga
Cannabis Industry Veteran On Market Trends, DEA Rescheduling, THC Types, Psychedelics And More
February 28, 2024
Tickers
THC
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.